TY - JOUR
T1 - Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome
AU - Kahsar-Miller, Melissa
AU - Boots, Larry R.
AU - Azziz, Ricardo
PY - 1999/3
Y1 - 1999/3
N2 - Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.
AB - Objective: To determine if a polymorphism of the dopamine D3 receptor gene (2 allele), which has been reported previously to be associated with polycystic ovary syndrome (PCOS) in a population of United States Hispanic women, is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient clinic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D3 receptor genotypes, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamine D3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as compared with controls. Furthermore, in contrast to a previous report, the 2:2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeastern United States did not demonstrate an association between a dopamine D3 receptor polymorphism and PCOS.
KW - Dopamine D receptor gene
KW - Polycystic ovary syndrome
KW - Polymorphism
UR - http://www.scopus.com/inward/record.url?scp=0032586940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032586940&partnerID=8YFLogxK
U2 - 10.1016/S0015-0282(98)00485-3
DO - 10.1016/S0015-0282(98)00485-3
M3 - Article
C2 - 10065778
AN - SCOPUS:0032586940
SN - 0015-0282
VL - 71
SP - 436
EP - 438
JO - Fertility and sterility
JF - Fertility and sterility
IS - 3
ER -